Does belatacept provide equivalent suppression of acute renal transplant rejection to ciclosporin?
Nature Clinical Practice Nephrology · 2006-03 · 2 (3) · 134-135
DOI: 10.1038/ncpneph0125 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nature Clinical Practice Nephrology, 2006-03. Verfasst von Mohamed H Sayegh und 1 weiteren Autor:innen. Beteiligte Einrichtung: Transplantation Medicine, Harvard Medical Schooland Brigham and Women's Hospital and Children's Hospital, Boston, MA 02115, USA. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 4 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Transplantation Medicine, Harvard Medical Schooland Brigham and Women's Hospital and Children's Hospital, Boston, MA 02115, USA.
Zitieren
APA
Sayegh, M. H., & Chandraker, A. (2006). Does belatacept provide equivalent suppression of acute renal transplant rejection to ciclosporin?. Nature Clinical Practice Nephrology, 2(3), 134-135. https://doi.org/10.1038/ncpneph0125
Vancouver
Sayegh MH, Chandraker A. Does belatacept provide equivalent suppression of acute renal transplant rejection to ciclosporin?. Nature Clinical Practice Nephrology. 2006;2(3):134-135. doi:10.1038/ncpneph0125
BibTeX
@article{Sayegh2006,
author = {Sayegh, Mohamed H and Chandraker, Anil},
title = {Does belatacept provide equivalent suppression of acute renal transplant rejection to ciclosporin?},
journal = {Nature Clinical Practice Nephrology},
year = {2006},
volume = {2},
number = {3},
pages = {134--135},
doi = {10.1038/ncpneph0125}
}
EUVIMED